A drug with a completely novel mechanism of action – targeting myocardial fibrosis – has shown some promising results in the treatment of heart failure with preserved ejection fraction, although the results are preliminary.

Among the patients who took the antifibrotic drug pirfenidone, there was a significant reduction in a marker of myocardial...